松永慎史

マツナガシンジ (Matsunaga Shinji)

基本情報

Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis

Kenji Sakuma, Shinji Matsunaga, Ikuo Nomura, Makoto Okuya, Taro Kishi, Nakao Iwata

Psychopharmacology 1-12 2018年5月22日査読有り
Anti-dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-analysis.

Kishi T, Ikuta T, Oya K, Matsunaga S, Matsuda Y, Iwata N

The international journal of neuropsychopharmacology 21(8) 748-757 2018年5月査読有り
The effects of memantine on behavioral disturbances in patients with Alzheimer’s disease: A meta-analysis

Taro Kishi, Shinji Matsunaga, Nakao Iwata

Neuropsychiatric Disease and Treatment 13 1909-1928 2017年7月20日査読有り
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: A network meta-analysis in a Japanese population

Taro Kishi, Toshikazu Ikuta, Shinji Matsunaga, Yuki Matsuda, Kazuto Oya, Nakao Iwata

Neuropsychiatric Disease and Treatment 13 1281-1302 2017年5月11日査読有り
Escitalopram versus paroxetine controlled release in major depressive disorder: A randomized trial

Taro Kishi, Yuki Matsuda, Shinji Matsunaga, Masatsugu Moriwaki, Yoichiro Otake, Kaku Akamatsu, Tomo Okochi, Shigeki Hirano, Toshihiko Funahashi, Momoko Okuda, Hideaki Tabuse, Kiyoshi Fujita, Nakao Iwata

Neuropsychiatric Disease and Treatment 13 117-125 2017年1月6日査読有り